PERRY GREGORY D Insider Trading
Get the latest insider transactions of PERRY GREGORY D. PERRY GREGORY D is See Remarks in QLT INC/BC ($QLTI) and Sr. VP & CFO in TRANSKARYOTIC THERAPIES INC ($TKTX) and VP, Finance & CEO in TRANSKARYOTIC THERAPIES INC ($TKTX) and VP, Finance and CFO in TRANSKARYOTIC THERAPIES INC ($TKTX) and Director in Ocata Therapeutics, Inc. ($ACTC) and in Aegerion Pharmaceuticals, Inc. ($AEGR) and Chief Financial Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and See Remarks in Aegerion Pharmaceuticals, Inc. ($AEGR) and in Kala Pharmaceuticals, Inc. ($KALA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Chief Financial and Business in Eleven Biotherapeutics, Inc. ($EBIO) and Chief Financial Officer in Finch Therapeutics Group, Inc. ($FNCH). Discover the current value of PERRY GREGORY D shares.
Address: 700 MAIN STREET CAMBRIDGE 02139MA
PERRY GREGORY D is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| TKTX | TRANSKARYOTIC THERAPIES INC | Sr. VP & CFO, VP, Finance and CFO, VP, Finance & CEO | 0 | 0.00 |
| SESN | Sesen Bio, Inc. | Chief Financial and Business | 0 | 0.00 |
| ACTC | Ocata Therapeutics, Inc. | Director | 0 | 0.00 |
| AEGR | Aegerion Pharmaceuticals, Inc. | 0 | 0.00 | |
| NVLN | NOVELION THERAPEUTICS INC. | See Remarks | 2,393 | 4,666.35 |
| KALA | Kala Pharmaceuticals, Inc. | 40,000 | ||
| FNCH | Finch Therapeutics Group, Inc. | Chief Financial Officer | 0 |
Insider Trading Transactions of PERRY GREGORY D
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2021 | KALA | Kala Pharmaceuticals, Inc ... | PERRY GREGORY D | Buy | 0.00 | 20,000 | 0 | 40,000 | |
| Mar 18 2021 | FNCH | Finch Therapeutics Group, ... | PERRY GREGORY D | Chief Financial Offic ... | Option Exercise | 17.00 | 55,386 | 941,562 | 55,386 |
| Jun 29 2020 | KALA | Kala Pharmaceuticals, Inc ... | PERRY GREGORY D | Director | Buy | 0.00 | 20,000 | 0 | 20,000 |
| Jun 07 2019 | KALA | Kala Pharmaceuticals, Inc ... | PERRY GREGORY D | Director | Option Exercise | 5.35 | 21,000 | 112,350 | 21,000 |
| Mar 02 2018 | KALA | Kala Pharmaceuticals, Inc ... | PERRY GREGORY D | Director | Option Exercise | 14.05 | 25,920 | 364,176 | 25,920 |
| May 11 2017 | QLTI | NOVELION THERAPEUTICS INC ... | PERRY GREGORY D | See Remarks | Buy | 0.00 | 2,393 | 0 | 2,393 |
| May 11 2017 | QLTI | NOVELION THERAPEUTICS INC ... | PERRY GREGORY D | See Remarks | Sell | 9.42 | 710 | 6,688 | 1,683 |
| May 11 2017 | QLTI | NOVELION THERAPEUTICS INC ... | PERRY GREGORY D | See Remarks | Option Exercise | 0.00 | 2,393 | 0 | 4,786 |
| Dec 27 2016 | QLTI | NOVELION THERAPEUTICS INC ... | PERRY GREGORY D | See Remarks | Option Exercise | 8.65 | 166,020 | 1,436,073 | 166,020 |
| Dec 01 2016 | QLTI | QLT INC/BC | PERRY GREGORY D | See Remarks | Option Exercise | 0.00 | 35,896 | 0 | 35,896 |
| Nov 30 2016 | AEGR | Aegerion Pharmaceuticals, ... | PERRY GREGORY D | Option Exercise | 19.58 | 200,000 | 3,916,000 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceuticals, ... | PERRY GREGORY D | Option Exercise | 19.52 | 40,000 | 780,800 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceuticals, ... | PERRY GREGORY D | Option Exercise | 5.71 | 200,000 | 1,142,000 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceuticals, ... | PERRY GREGORY D | Option Exercise | 2.46 | 69,000 | 169,740 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceuticals, ... | PERRY GREGORY D | Option Exercise | 0.00 | 35,000 | 0 | 0 | |
| May 11 2016 | AEGR | Aegerion Pharmaceuticals, ... | PERRY GREGORY D | See Remarks | Option Exercise | 2.46 | 69,000 | 169,740 | 69,000 |
| May 11 2016 | AEGR | Aegerion Pharmaceuticals, ... | PERRY GREGORY D | See Remarks | Option Exercise | 0.00 | 35,000 | 0 | 35,000 |
| Feb 17 2016 | AEGR | Aegerion Pharmaceuticals, ... | PERRY GREGORY D | See Remarks | Option Exercise | 5.71 | 200,000 | 1,142,000 | 200,000 |
| Feb 11 2016 | ACTC | Ocata Therapeutics, Inc. | PERRY GREGORY D | Director | Sell | 8.50 | 21,417 | 182,045 | 0 |
| Feb 11 2016 | ACTC | Ocata Therapeutics, Inc. | PERRY GREGORY D | Director | Option Exercise | 10.37 | 417 | 4,324 | 0 |
| Feb 11 2016 | ACTC | Ocata Therapeutics, Inc. | PERRY GREGORY D | Director | Option Exercise | 9.00 | 5,000 | 45,000 | 0 |
| Feb 11 2016 | ACTC | Ocata Therapeutics, Inc. | PERRY GREGORY D | Director | Option Exercise | 5.79 | 5,000 | 28,950 | 0 |
| Feb 11 2016 | ACTC | Ocata Therapeutics, Inc. | PERRY GREGORY D | Director | Option Exercise | 6.17 | 5,000 | 30,850 | 0 |
| Feb 11 2016 | ACTC | Ocata Therapeutics, Inc. | PERRY GREGORY D | Director | Option Exercise | 6.39 | 5,000 | 31,950 | 0 |
| Feb 11 2016 | ACTC | Ocata Therapeutics, Inc. | PERRY GREGORY D | Director | Option Exercise | 8.36 | 5,000 | 41,800 | 0 |
| Jan 04 2016 | ACTC | Ocata Therapeutics, Inc. | PERRY GREGORY D | Director | Buy | 0.00 | 1,250 | 0 | 21,417 |
| Jan 04 2016 | ACTC | Ocata Therapeutics, Inc. | PERRY GREGORY D | Director | Option Exercise | 8.36 | 5,000 | 41,800 | 5,000 |
| Oct 01 2015 | ACTC | Ocata Therapeutics, Inc. | PERRY GREGORY D | Director | Buy | 0.00 | 1,250 | 0 | 20,167 |
| Aug 06 2015 | AEGR | Aegerion Pharmaceuticals, ... | PERRY GREGORY D | Chief Financial Offic ... | Option Exercise | 19.52 | 40,000 | 780,800 | 40,000 |
| Aug 04 2015 | AEGR | Aegerion Pharmaceuticals, ... | PERRY GREGORY D | Chief Financial Offic ... | Option Exercise | 19.58 | 200,000 | 3,916,000 | 200,000 |
| Jul 02 2015 | ACTC | Ocata Therapeutics, Inc. | PERRY GREGORY D | Director | Buy | 0.00 | 1,250 | 0 | 18,917 |
| Apr 01 2015 | ACTC | Ocata Therapeutics, Inc. | PERRY GREGORY D | Director | Buy | 0.00 | 1,250 | 0 | 17,667 |
| Feb 27 2015 | EBIO | Eleven Biotherapeutics, I ... | PERRY GREGORY D | Chief Financial and B ... | Option Exercise | 10.39 | 57,500 | 597,425 | 203,248 |
| Mar 28 2005 | TKTX | TRANSKARYOTIC THERAPIES I ... | PERRY GREGORY D | Sr. VP & CFO | Option Exercise | 23.79 | 15,000 | 356,850 | 15,000 |
| Nov 15 2004 | TKTX | TRANSKARYOTIC THERAPIES I ... | PERRY GREGORY D | VP, Finance and CFO | Option Exercise | 21.74 | 32,500 | 706,550 | 32,500 |
| Mar 26 2004 | TKTX | TRANSKARYOTIC THERAPIES I ... | PERRY GREGORY D | VP, Finance & CEO | Option Exercise | 10.62 | 8,959 | 95,145 | 8,959 |